Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Oneview Healthcare (ONE) extends its contract with Victoria’s Epworth Healthcare by five years
  • ONE provides digital tools to improve the care experience for patients, families and carers
  • Epworth uses Oneview’s digital platform at eight of its hospitals in around 1440 beds
  • Under the renewal, Epworth will migrate to ONE’s Next Generation CXP Enterprise platform
  • Shares in Oneview Healthcare are up 11 per cent to 45.5 cents at 1:10 pm AEST

Oneview Healthcare (ONE) has penned a five-year contract extension with Victoria-based Epworth Healthcare.

ONE provides digital tools, including a digital platform and dedicated devices, for patients, families and caregivers to improve the care experience.

In terms of bed numbers, Epworth is the company’s largest Australian customer and its second largest globally.

In fact, Epworth has already deployed Oneview’s digital platform throughout eight of its hospital locations, in around 1440 beds.

Under the renewed contract, Epworth will migrate to ONE’s new Next Generation CXP Enterprise platform and deploy GMS-certified healthcare-grade 22-inch android devices across its places of care.

Additionally, the Victorian customer is set to expand its footprint with Oneview at the Epworth Eastern redevelopment at Box Hill with a further 63 beds.

“[Epworth] have been the inspiration for much of our innovation in the Australian market and encouraged us to broaden the platform to include an extensive suite of care team applications, which have become an integral part of their care delivery model,” ONE Chief Executive Officer James Fitter said.

Epworth Healthcare Group CEO Dr Lachlan Henderson added Oneview’s platform had changed the way the company delivered care to patients.

“Our nurses and doctors access our Oneview point-of-care screens 20,000 times a day, allowing them to update patient information and access medical imaging, radiology and pathology results at the bedside,” Dr Henderson said.

Following the announcement, shares in Oneview Healthcare were trading 11 per cent higher at 45.5 cents each at 1:10 pm AEST.

ONE by the numbers
More From The Market Herald
Race Oncology (ASX:RAC) - CEO, Phillip Lynch

" Race Oncology (ASX:RAC) posts nominal decline in cash

Race Oncology (RAC) has posted a nominal decline in cash and equivalents as of 30 September 2021 to $8.94 million, down from $9.32...
Prescient Therapeutics (ASX:PTX) - Managing Director and CEO, Steven Yatomi Clarke

" Prescient Therapeutics (ASX:PTX) logs timely progress across anti-cancer programs in Q3

Prescient Therapeutics (PTX) says it is poised to reach value-adding milestones across its anti-cancer programs after wrapping up the September quarter with $14.8...
Neuren Pharmaceuticals (ASX:NEU) - CEO, Jon Pilcher

" Neuren Pharmaceuticals (ASX:NEU) highlights trial progress in September quarterly

Neuren Pharmaceuticals (NEU) has released its September quarterly report, highlighting the progress with its upcoming clinical trials.

" Invion (ASX:IVX) sees complete regression of tumours in breast cancer trial

Invion (IVX) shares have soared following its latest trial results, demonstrating a complete regression in tumours following in vivo treatment.